NTD Newsroom comprises teams of reporters, editors, and producers assigned to cover breaking news and other stories.


NTD Newsroom

NTD Plus

News

News you can trust from the U.S. and around the world. Critical information and insight. We cover the stories that others don’t. NTD News Today airs Monday–Friday at 11 a.m. ET.

NTD News Today

Pentagon Scraps Deployment of 4,000 Troops to Poland

9/11 Memorial and Museum Adds 7th Moment of Silence

AT&T, T-Mobile, Verizon Launch Joint Venture to Tackle Dead Zones

Stefania Cox is an NTD News anchor and national correspondent based at the network's global headquarters in New York City. Stefania anchors "NTD Newsroom," and co-anchors "NTD News Today" weekdays at 10:00 am ET.

Stefania Cox

Trump Committed to US Defense, Prosperity, Amid China Talks: Expert

Jerome Powell Ends Tenure as Fed Chair

US Government Sues Chick-fil-A Over Religious Rights

California Gubernatorial Candidates Make Closing Pitches to Voters 

House Passes 1st Fiscal Year 2027 Appropriations Bill

Jason Blair is a national correspondent for NTD News based in California. 

Jason Blair

Federal Judge Partly Blocks Texas Immigration Law

Trump Announces National Garden of American Heroes Plans

NTD News Today Full Broadcast (May 15)

Paul Greaney is an NTD news anchor and producer. Since joining the company in 2018, he has anchored the station’s flagship Evening News broadcast, launched the NTD Business show, and produced documentary reports on pointed issues. 

The highlight of Paul’s time in the field was his coverage of the Hong Kong pro-democracy protests in 2019.

Paul Greaney

NTD News Today Full Broadcast (May 14)

Kevin Hogan is an NTD News data reporter and national correspondent based at the network's global headquarters in New York City. Kevin covers breaking news, as well as U.S. and global current events. He conveys the news through data visualizations and investigates pressing issues.

Kevin Hogan

NTD News Today Full Broadcast (May 13)

NTD News Today Full Broadcast (May 12)

NTD News Today Full Broadcast (May 11)

NTD News Today Full Broadcast (May 8)

NTD News Today Full Broadcast (May 7)

NTD News Today Full Broadcast (May 6)

NTD News Today Full Broadcast (May 5)

NTD News Today Full Broadcast (May 4)

Fast, compelling, first-hand news from China. China in Focus airs Monday–Friday at 8 p.m. ET.

China in Focus

China Sends Warships to Pacific Drill as Tensions With Japan Rise

Reuters is a news agency owned by Thomson Reuters. It employs around 2,500 journalists and 600 photojournalists in about 200 locations worldwide writing in 16 languages.

Reuters

We present news that is truthful and based on facts, outside of the political fog. Instead of focusing on the negative things happening around us, our mission is to give our viewers a good morning with empathetic and uplifting stories. Our aim is to provide an antidote to negativity by shining a light on the best side of people. We speak to inspiring people who positively impact communities, pursue topics that represent our common human values, and will never miss an opportunity to bring you heartwarming stories.

NTD Good Morning

2 US Embassy Personnel Assigned to Cartel Case Killed in Car Accident

The Associated Press is an American not-for-profit news agency headquartered in New York City. 

The Associated Press

US News

Gunman Kills 8 Children, Including 7 of His Own, in Louisiana Mass Shooting

Flora Hua is a reporter based at NTD's global headquarters in New York City, where she covers China news, U.S.-China relations, and human rights issues. Flora primarily contributes to NTD's "China in Focus."  

Flora Hua

Trump: Seized Iranian Ship May Have ‘A Gift From China’

Joseph Lord is a congressional reporter for The Epoch Times.


Joseph Lord

Aldgra Fredly is a freelance writer covering U.S. and Asia Pacific news for The Epoch Times.

Aldgra Fredly

Former NYC Mayor Rudy Giuliani Hospitalized in Critical Condition: Spokesman

Wildfires Across Georgia and Florida Have Destroyed Nearly 50 Homes and Are Forcing Evacuations

US Warns of China Hacks via Routers, Smart Devices

Juliet Song is an international correspondent exclusively covering China news for NTD. She primarily contributes to NTD's "China in Focus," covering U.S.-China relations, the Chinese regime's human rights abuses, and domestic unrest inside China.

Juliet Song

2 Americans Among Suspected Communist Rebels Killed in Clashes With Troops, Philippine Officials Say

Ryan Morgan is a reporter for The Epoch Times focusing on military and foreign affairs. He was previously a news writer for NTD. 


Ryan Morgan

Mari Otsu is NTD's White House correspondent based in Washington. 

Mari Otsu

World News

Middle East

Iran

3 US Warships Fend Off Iranian Attacks, Trump Says Ceasefire Still Holds

Health News

3 Dead in Suspected Hantavirus Outbreak on Cruise Ship in Atlantic Ocean: WHO

Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at zack.stieber@epochtimes.com

Zachary Stieber

The Food and Drug Administration (FDA) on Aug. 25 stated that it has suspended approval for a vaccine against chikungunya, a mosquito-borne virus.

Because of reports of serious adverse events following administration of the vaccine, the FDA’s Center for Biologics Evaluation and Research (CBER) “believes [the] vaccine is not safe and that continued administration to the public would pose a danger to health,” the FDA <a href="https://www.fda.gov/safety/medical-product-safety-information/fda-update-safety-ixchiq-chikungunya-vaccine-live-fda-suspends-biologics-license-fda-safety">said</a> in a statement.

France-based Valneva makes the vaccine, known as Ixchiq.

“As we determine potential next steps, and as the clear threat of chikungunya continues to escalate globally, Valneva remains fully committed to maintaining access to our vaccine as a global health tool for addressing and preventing outbreaks of this devastating illness,” Valneva CEO Thomas Lingelbach <a href="https://valneva.com/wp-content/uploads/2025/08/2025_08_25_FDA_IXCHIQ_Update_PR_EN_Final2.pdf">said</a> in a statement.

The FDA originally approved Ixchiq in 2023 to prevent disease caused by the chikungunya virus in adults deemed to have an increased risk of exposure. The Centers for Disease Control and Prevention (CDC) in 2024 recommended the vaccine for people traveling to certain countries.

Health officials <a href="https://www.theepochtimes.com/health/us-advises-older-adults-not-to-receive-chikungunya-vaccine-for-now-5856323">said</a> in an alert in May that they were advising a pause in administering the vaccine to elderly adults because of reports that some of those vaccinated had been experiencing serious adverse events (SAEs), including neurologic and cardiac problems.

This included 38 SAE reports for 32 unique cases (seven U.S. cases, 25 foreign cases), including 21 hospitalizations and three deaths.

After CBER Director Dr. Vinay Prasad <a href="https://www.theepochtimes.com/us/top-fda-vaccine-official-departs-agency-5894223">resigned</a>, the FDA in early August <a href="https://www.theepochtimes.com/health/fda-ends-suspension-of-chikungunya-vaccine-adjusts-label-5898252">ended</a> the recommended suspension, stating that an updated assessment of risks and benefits for Ixchiq showed that the benefits still outweighed the risks for some people.

In the new announcement, regulators said that is no longer the case.

The latest risk-benefit assessment includes four new foreign reports that have come to light since the FDA lifted the recommended pause, including a report of problems following vaccination in a 55-year-old male.

Prasad <a href="https://www.documentcloud.org/documents/26073627-fda-ixchiq-suspension-memorandum/">said</a> in a memorandum dated Aug. 22 that of the 32 cases, five tested positive for the vaccine strain of the virus, making it nearly certain that the vaccine caused the problem.

“There are reasonable grounds to believe the risks of the vaccine outweigh its benefits, and that it poses a danger to health,” Prasad said. “Therefore, CBER is suspending approval.”

Chikungunya causes symptoms in most people who are infected with the virus, according to the CDC. Symptoms can include fever, joint pain, and inflammation.

Another vaccine against chikungunya, Vimkunya, is still available in the United States. The FDA approved it in April for people 12 years of age and older, and the CDC recommends it for people traveling to areas with chikungunya outbreaks and for laboratory workers who could become exposed to the virus in their work.

Vimkunya uses a molecule resembling the chikungunya virus to trigger an immune response. Ixchiq contains a weakened form of the virus.

Share prices of Valneva dipped by about 21 percent after the FDA’s suspension.

Valneva described the move as sudden. The company said that the SAEs recorded following vaccination featured symptoms consistent with those reported during clinical trials and that the labels accurately list warnings and precautions.

The label warns that Ixchiq could cause “serious, severe, or prolonged chikungunya-like illness,” citing trial data and reports following approval.

“Valneva is continuing to investigate these cases in detail and if warranted will pursue further steps in connection with FDA’s decision in accordance with applicable statutory procedures,” it stated.

<em>From <a href="https://www.theepochtimes.com/us/fda-suspends-license-for-chikungunya-vaccine-5905657">The Epoch Times</a></em>

Latest

Paywall Related

04_Top Stories

Free for Subscribers

Latest Clips

Management

03_Featured

Latest and breaking news, documentaries, movies, and lifestyle content on NTD+.
 
Empower your knowledge and elevate your spirit with NTD+, your go-to destination for truthful news, insightful documentaries, and captivating lifestyle content that enriches your life.

FDA Suspends License for Chikungunya Vaccine

Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.


Naveen Athrappully

Musk Companies Sue Apple and OpenAI, Allege Monopolistic Practices

South Korea’s Lee Navigating US Ties But Leaning Toward Communist Neighbors: Analyst

China's Evergrande Delisted After Spectacular Fall

Germany to Take Part in Ukrainian Security Guarantees

Ukraine Seeks at Least $1 Billion Monthly for US Weapons Purchases: Zelenskyy

Germany Charges US Citizen With Offering Military Intelligence to China

Alice Tang

NTD News Today Full Broadcast (Aug. 25)

Typhoon Kajiki Drenches Southern China’s Hainan Island, Heads Toward Vietnam

Sean Marshall is a reporter based at NTD's global headquarters in New York City, primarily covering business and technology trends. 